Beijing Allcure Medical Technology, a Chinese medical start-up that develops cloud-based radiotherapy technology, has raised an extended Series A round of funding worth RMB180 million ($27 million).
Sequoia India and US-based Sands Capital Ventures have led a $27.4 million Series B round of funding for Mitra Biotech, an India and US-based company that focuses on personalized cancer therapies.
CVC Capital Partners has once again entered into a partnership with Indonesia’s Lippo Group, agreeing a IDR2.2 trillion ($165.7 million) deal to invest in Siloam International Hospitals, which is controlled by the Riady family-owned business.
Chinese healthcare-focused VC firm I-Bridge Capital has launched a joint venture (JV) with Israeli biopharmaceutical company BioLineRx that will target cross-border penetration of Chinese markets.
Quadrant Private Equity has acquired a majority stake in Injury Treatment, an Australia-based provider of injury prevention and rehabilitation services to employers and insurers, for an undisclosed sum.
Chinese mobile healthcare services provider Shanghai KingYee and its independent unit Quyiyuan - which operates a medical services booking app - have raised a combined RMB313 million ($47 million) in their latest rounds of funding.
SeaLink Capital Partners and the International Finance Corporation have committed a INR 1 billion ($14.9 million) Series C round to India-based dialysis clinic chain NephroPlus.
Indian pharmaceutical products developer Laurus Labs has filed for a domestic IPO, offering a partial exit for backers Warburg Pincus and Eight Roads Ventures.
Indian biopharmaceutical company Vyome Biosciences has raised a $14 million Series C funding round led by US investors Perceptive Advisors and Romulus Capital.
A US-based healthcare fund backed by Microsoft founder Bill Gates has led a A$4.5 million ($3.5 million) investment round in Australian medical technology company Atomo Diagnostics.
WestBridge Capital Partners has led a $15.6 million Series A round of funding for Innovaccer, a healthcare-focused IT outsourcing start-up with bases in Palo Alto and New Delhi.
Singapore’s Golden Gate Ventures has committed $2.5 million to a Series A funding round for Indonesian healthcare information portal operator Alodokter.
The Australian government has seeded $250 million ($191 million) from its Medical Research Future Fund (MRFF) to a biomedical technology-focused venture investment vehicle. It will match private sector commitments, bringing the total available for deployment...
PICC Property and Casualty, a subsidiary of People's Insurance Company of China (PICC), has led a $64 million funding round for cloud-based medical and healthcare services provider Neusoft Xikang.
Primavera Capital and Shanghai Pharmaceuticals have agreed to buy Australia-listed nutrition and healthcare products company Vitaco for approximately A$313 million ($238 million).
MPM Capital, a US venture firm focused on early-stage life science companies, has launched a new investment vehicle in partnership with Japanese pharmaceutical company Astellas Pharma.
KKR will exit India-based Gland Pharma as Shanghai Fosun Pharmaceutical acquires a majority stake in the business for up to $1.26 billion. KKR’s share of the proceeds will be $576.3 million, more than twice what it invested in Gland in 2014.
Australian life sciences-focused VC firm Brandon Capital has expanded the mandate of its third Medical Research Commercialization Fund (MRCF) to include New Zealand.
KKR will sell its 45% stake in Australia-based healthcare provider GenesisCare as China Resources Group and Macquarie Capital agreed to buy a majority interest in the business.
EQT Partners has agreed to sell its 49% stake in Singapore’s Econ Healthcare to the company’s founder Chu-Poh Ong ahead of a regional expansion initiative.
Hermed Capital Healthcare Fund, a PE vehicle managed by Shanghai Fosun Pharmaceutical Group and Korea’s SK Group, has committed $4 million to a China expansion drive by US-based Diamedica.
TPG Capital’s growth investment arm has paid $33 million for a significant majority stake in Rhea Healthcare, which operates a network of mother and child care centers in India under the Motherhood brand.
Gengmei, a Chinese cosmetic surgery social networking app backed by several VC investors, has raised an undisclosed amount of Series C funding from Chinese companies Suning Commerce Group and Tencent Holdings.
Creador has committed INR1.2 billion ($17.6 million) to India-based pharmaceutical developer Corona Remedies.